Published: 2019-03-25

A study of cardiac changes in asymptomatic diabetic patients in comparison with normal population

Mukhtarahmed Bendigeri, Rizwan P. Sadique, Asbin Abdul Aziz, Prakruthi Jaladhar


Background: India is predicted to bear the greatest Coronary artery disease (CAD) burden, according to the estimates from the global burden of disease study. Majority of the time the patient of diabetes presents with complications like Myocardial infarction (MI), heart failure, being end stages of cardiovascular disease associated with other macro and micro-vascular complications.

Methods: This study was done in view of screening the asymptomatic diabetic individuals presenting to our hospital for any evidence of early cardio-vascular manifestations. With the aid of non-invasive testing such as electrocardiography (ECG) and 2D echo the early changes were noted and compared with the normal population and the cardiac status thus evaluated. A total of 106 patients (53 were diabetic and 53 non-diabetic controls) were included in the study in order to compare the ECG and 2D echo findings among the population. The main aim of the present study was to observe the ECG manifestations in diabetic patients without overt symptoms of any cardiac disease and to evaluate the ECG changes along with 2D echocardiogram in asymptomatic diabetic patients and compare with normal population.

Results: From the study, it was observed that majority among the diabetic population were found to have statistically significant changes in the ECG like PR interval prolongation, T wave inversions and QT interval prolongation. 2D ECHO studied showed the presence of Left ventricular diastolic dysfunction and Regional wall motion abnormalities to be evident among the diabetic population.

Conclusions: It was concluded from the study that diabetic patients have a higher risk of cardiovascular morbidities compared to the general population and ECG changes are observed even when they are clinically asymptomatic. This observation has been confirmed by the 2D echo findings. It is essential to screen diabetic patients at an early stage to prevent cardiovascular complications. ECG being a relatively cheap and non-invasive investigation should be utilized to screen diabetics for the same.


Diabetes Mellitus, ECG changes, Cardiac Manifestations

Full Text:



Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American heart association/American stroke association. Stroke. 2014;45(1):315-3.

Labarthe DR. Epidemiology and prevention of cardiovascular diseases: a global challenge. Jones & Bartlett Publishers; 2010:25.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, H et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12.

Young LH, Frans JT, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547-55.

Laitinen T, Lyyra‐Laitinen T, Huopio H, Vauhkonen I, Halonen T, Hartikainen J, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13(2):97-105.

Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, et al. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the Eurodiab prospective complications study. Diab Care. 2007;30(8):2057-63.

Nelson MR, Daniel KR, Carr JJ, Freedman BI, Prineas RJ, Bowden DW et al. Associations between electrocardiographic interval durations and coronary artery calcium scores: the diabetes heart Study. Pacing Clin Electrophysiol. 2008;31:314-21.

Žďárská D, Pelíšková P, Charvát J, Slavíček J, Mlček M, Medová E, et al. ECG body surface mapping (BSM) in type 1 diabetic patients. Physiol Res. 2007;56:403-10.

Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, et al. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the Eurodiab prospective complications study. Diab Care. 2007;30(8):2057-63.

Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Döring A, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diab Care. 2008;31(3):556-61.

Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Peters D, et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the oregon sudden unexpected death study. Circulat. 2009;119(5):663-70.

Gómez-Marcos MA, Recio-Rodríguez JI, Rodríguez-Sánchez E, Castaño-Sánchez Y, de Cabo-Laso A, Sánchez-Salgado B, et al. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. Lod-diabetes study protocol. BMC Pub Heal. 2010;10(1):143.

Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, et al. Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The life study. Am J Hypertension. 2010;23(8):845-1.

Barrios V, Escobar C, Calderón A, Echarri R, Barrios S, Navarro-Cid J. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study. J Renin-Angioten-Aldoster Syst. 2009;10(3):168-73.

Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, et al. Life study investigators. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: The Life study. J Am Coll Cardiol. 2001;38(2):514-20.